Case study: three acute 241Am inhalation exposures with DTPA therapy.

Eugene H Carbaugh1, Timothy P Lynch, Curt N Cannon

  • 1Battelle-Pacific Northwest Division, Richland, WA 99352, USA. gene.carbaugh@pnl.gov

Health Physics
|September 15, 2010
PubMed
Summary

Workers exposed to americium-241 (Am) oxide received timely chelation therapy, leading to effective removal and no adverse health effects. Lung retention was longer than expected, highlighting the importance of monitoring and tailored treatment for internal Am contamination.